All filters
Slidesets
Changes of the Composition of the Hepatitis B Virus (HBV) surface Antigen (HBsAg) are Associated with HBsAg Loss during Nucleos(tid)e Analogues and Peg-interferon-alfa2a Treatment- M. Pfefferkorn
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Model for Care - Focus on HCV, Introductory Lecture- Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Pakistan’s Model for Care- Huma Qureshi, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Evaluation of the Hepatitis C Care Cascade in the Country of Georgia: Monitoring Progress towards Elimination- T. Tsertsvadze
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Strategies towards Elimination of Hepatitis C in Iceland: Models of Care for the Treatment as Prevention for Hepatitis C (TraP HeP C) Program- M. Gottfredsson
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Micro-Elimination of Hepatitis C amongst People Living with HIV (PLHIV) in Punjab, India- P. Katapur
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Integration of Hepatitis C Treatment Services with Harm Reduction Service Centers for People who Inject Drugs in Kenya: Experience from Test and Link to Care for Injecting Drug Users Study- M. Nyakowa
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Towards the Elimination of HCV in British Columbia: A strategy to Address the “messy middle”- B. Conway
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario- D. Smookler
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study- A. Palayew
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Mongolia’s Model for Care- Naranjargal Dashdorj, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Hepatitis C Elimination in the Netherlands (CELINE): a Nationwide Study Retrieving Lost to Follow-Up Chronic Hepatitis C Patients- M. Van Dijk
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
Oral Prescription Opioid Use should be Considered a Risk Factor for HCV Infection: Another Step Toward HCV Elimination- B. Hack
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Slidesets
The ABC of viral hepatitis- Mark Thursz, MRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Burden of Liver Disease in North Africa- Ayman Yosry
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Clinical spectrum of liver disease in Africa- Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
The global challenge of viral hepatitis- Olufunmilayo Lesi, MD, MBA, FMCP, FWACP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis D - a forgotten foe?- Richard Njouom, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis B stigma by association with HIV in Zambia- Michael Vinikoor
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Prevalence estimates of chronic hepatitis B virus infection: a comparative study of four sources and implications for burden assessment in sub-Saharan Africa- Nora Schmit
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Epidemiology of hepatitis B and evaluation of vaccine efficacy in a census-based community serosurvey of Ndirande township in Blantyre, Malawi- Alexander Stockdale
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018